J&J Offers Sliding Timeframe for Covid Boosters Based on Individual Patient and Geographic Need

 
• By Sarah Karlin-Smith
  
J&J Janssen sign
J&J’s COVID-19 booster application heads to the FDA’s VRBPAC on 15 October • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers